These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7968913)

  • 1. [Effect of molsidomine on esophageal motility in man].
    Allescher HD; Willis S; Stoschus B; Schusdziarra V; Classen M
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():71-2. PubMed ID: 7968913
    [No Abstract]   [Full Text] [Related]  

  • 2. Double blind placebo controlled study on the effect of the nitric oxide donor molsidomin and the 5-HT3 antagonist ondansetron on human esophageal motility.
    Willis S; Allescher HD; Stoschus B; Schusdziarra V; Classen M; Schumpelick V
    Z Gastroenterol; 1994 Nov; 32(11):632-6. PubMed ID: 7886971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of molsidomine on esophageal motility in patients with non-cardiac thoracic pain].
    Korda P; Barnert J; Schmidbaur W; Wienbeck M
    Med Klin (Munich); 1994 Jul; 89 Suppl 2():73-4. PubMed ID: 7968914
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of erythromycin on human esophageal motility is mediated by serotonin receptors.
    Koutsoumbi P; Epanomeritakis E; Tsiaoussis J; Athanasakis H; Chrysos E; Zoras O; Vassilakis JS; Xynos E
    Am J Gastroenterol; 2000 Dec; 95(12):3388-92. PubMed ID: 11151866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of the lower esophageal sphincter pressure after oral molsidomine by sydnonimine plasma concentrations.
    Stoschus B; Fernandez I; Heller J; Neubrand M; Sauerbruch T
    Hepatogastroenterology; 1999; 46(26):933-7. PubMed ID: 10370642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intravenous erythromycin on esophageal motility in healthy subjects.
    Tzovaras G; Xynos E; Chrysos E; Mantides A; Vassilakis JS
    Am J Surg; 1996 Mar; 171(3):316-9. PubMed ID: 8615464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intravenous midazolam on esophageal motility testing in normal human volunteers.
    Marsh JK; Hoffman SM; Dmuchowski CF
    Am J Gastroenterol; 1993 Jun; 88(6):860-3. PubMed ID: 8503381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of sildenafil on lower esophageal sphincter and body motility in normal male adults.
    Rhee PL; Hyun JG; Lee JH; Kim YH; Son HJ; Kim JJ; Paik SW; Rhee JC; Choi KW
    Am J Gastroenterol; 2001 Dec; 96(12):3251-7. PubMed ID: 11774933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers.
    Blonski W; Vela MF; Freeman J; Sharma N; Castell DO
    J Clin Gastroenterol; 2009 Mar; 43(3):253-60. PubMed ID: 18987553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cisapride on secondary peristalsis in patients with gastroesophageal reflux disease.
    Holloway RH; Penagini R; Schoeman MN; Dent J
    Am J Gastroenterol; 1999 Mar; 94(3):799-803. PubMed ID: 10086669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous nitric oxide in the control of esophageal motility in humans.
    Konturek JW; Thor P; Lukaszyk A; Gabryelewicz A; Konturek SJ; Domschke W
    J Physiol Pharmacol; 1997 Jun; 48(2):201-9. PubMed ID: 9223025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
    Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM
    Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide--a major player in esophageal motility.
    Zayat EN; Schuster MM
    Am J Gastroenterol; 2000 Jun; 95(6):1584-5. PubMed ID: 10894602
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison between the effects of pirenzepine and L-hyoscyamine in man.
    Jaup BH; Stockbrügger RW; Dotevall G
    Scand J Gastroenterol Suppl; 1982; 72():119-24. PubMed ID: 6957979
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of Nissen-Rossetti fundoplication on the motor function of swallowing in patients with reflux diseases].
    Wallner G; Misiuna P; Dabrowski A; Abramowicz K; Polkowski W; Mijal M
    Wiad Lek; 1997; 50 Suppl 1 Pt 1():282-92. PubMed ID: 9446370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of mosapride on esophageal motility and bolus transit in asymptomatic volunteers.
    Cho YK; Choi MG; Han HW; Park JM; Oh JH; Jeong JJ; Cho YS; Lee IS; Kim SW; Choi KY; Chung IS
    J Clin Gastroenterol; 2006 Apr; 40(4):286-92. PubMed ID: 16633098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SR 48692, a specific neurotensin receptor antagonist, has no effect on oesophageal motility in humans.
    Zerbib F; Piche T; Charles F; Galmiche JP; Bruley des Varannes S
    Aliment Pharmacol Ther; 2004 Apr; 19(8):931-9. PubMed ID: 15080855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic stimulation induces asynchrony between the circular and longitudinal muscle contraction during esophageal peristalsis.
    Korsapati H; Babaei A; Bhargava V; Mittal RK
    Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G694-8. PubMed ID: 18187516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between pressure wave amplitude and esophageal bolus clearance assessed by combined manometry and multichannel intraluminal impedance measurement.
    Nguyen NQ; Tippett M; Smout AJ; Holloway RH
    Am J Gastroenterol; 2006 Nov; 101(11):2476-84. PubMed ID: 17029613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sodium valproate on esophageal motility in healthy subjects and patients with gastroesophageal reflux.
    Tzovaras G; Tsiaoussis J; Athanasakis E; Zoras O; Xynos E; Chrysos E
    Scand J Gastroenterol; 2004 Jun; 39(6):521-6. PubMed ID: 15223674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.